Founding membership
Join the waitlist.
Be first in line.
Founding memberships are limited to the first 100 members, with pricing locked for 3 years. From $4.11 a day.
- 100+ biomarkers, including advanced longevity markers most clinics miss
- Your results tracked over time on a personal dashboard
- Evidence-based longevity education and a private member community
- Priority access to cutting-edge clinical trials as they launch
Membership tiers
Choose the level of
depth you want
Founding member pricing is locked at the rate below for your first 3 years — regardless of future price increases.
Founding member rate — locked for 3 years
Annual comprehensive screening across core longevity biomarkers, general guidance on your results, your personal dashboard, and the AIHL Longevity Education Program.
- PhenoAge biological age estimate
- Core blood panel: metabolic, lipids, glucose, HbA1c & insulin
- Thyroid function & inflammatory markers (hsCRP, ESR)
- Annual DEXA body composition scan
- AIHL Longevity Education Program
- General guidance on your results
- Personal dashboard with wearable integration
- Private member community
- Priority access to upcoming trials
Founding member rate — locked for 3 years
Everything in Tier 1, plus an expanded panel covering micronutrients, hormones, advanced cardiovascular markers, and longevity research biomarkers.
- Everything in Tier 1
- Expanded micronutrient panel (iron, B12, folate, zinc, copper, Vit D)
- Full sex hormone panel
- Omega Index, ApoB/A1 & homocysteine
- Longevity cytokine panel (TNF, TGF, IL-6, IL-11, GDF15)
Founding member rate — locked for 3 years
Our most comprehensive assessment. Adds Klotho, epigenetic age testing, ApoE genotyping, and extended hormonal and metabolic profiling.
- Everything in Tier 2
- Extended metabolic & cardiovascular (Lp(a), cystatin C, OGTT)
- Advanced hormonal panel (GH, IGF-1, cortisol, DHEA)
- Klotho & NAD+ levels
- TruAge epigenetic age testing
- ApoE genotyping
- Annual doctor review
AIHL provides screening, education and community. It does not diagnose or treat medical conditions, and complements your GP rather than replacing them. Pricing shown in AUD.
Scientific Perspectives
What leading researchers
say about our approach
Longevity medicine is rich in emerging science, yet largely shaped by influencers and commercial interests rather than the rigour patients deserve. Translating the best available science into a rigorous, clinically grounded methodology — disciplined, honest and clinician-led — may be the most important contribution academic medicine can make to human health in a generation.
Professor Pete Smith, BMedSci, MBBS, FRACP, PhD
Allergist and Immunologist
AIHL represents the shift preventive health has long needed — from reactive care to a science-based approach built on longitudinal biomarker tracking and personalized intervention. The panel itself reflects real scientific judgment with established relevance to biological age trajectory, not a consumer wellness checklist. Pairing that with real research access, including geroprotective trials, is the kind of rigor this field needs more of.
Matt Kaeberlein, PhD
Biogerontologist
Former Professor, University of Washington